» Articles » PMID: 38827473

Effects of Extracellular Vesicles for Ischemic Stroke: A Meta‑analysis of Preclinical Studies

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2024 Jun 3
PMID 38827473
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic stroke is a common occurrence worldwide, posing a severe threat to human health and leading to negative financial impacts. Currently available treatments still have numerous limitations. As research progresses, extracellular vesicles are being found to have therapeutic potential in ischemic stroke. In the present study, the literature on extracellular vesicle therapy in animal studies of ischemic stroke was screened by searching databases, including PubMed, Embase, Medline, Web of Science and the Cochrane Library. The main outcomes of the present study were the neurological function score, apoptotic rate and infarct volumes. The secondary outcomes were pro-inflammatory factors, including tumor necrosis factor-α (TNF-α), interleukin (IL)-1β and IL-6. The study quality was assessed using the CAMARADES Checklist. Subgroup analyses were performed to evaluate factors influencing extracellular vesicle therapy. Review Man3ager5.3 was used for data analysis. A total of 20 relevant articles were included in the present meta-analysis. The comprehensive analysis revealed that extracellular vesicles exerted a significant beneficial effect on neurobehavioral function, reducing the infarct volume and decreasing the apoptotic rate. Moreover, extracellular vesicles were found to promote nerve recovery by inhibiting pro-inflammatory factors (TNF-α, IL-1β and IL-6). On the whole, the present meta-analysis examined the combined effects of extracellular vesicles on nerve function, infarct volume, apoptosis and inflammation, which provides a foundation for the clinical study of extracellular vesicles.

References
1.
Li S, Luo L, He Y, Li R, Xiang Y, Xing Z . Dental pulp stem cell-derived exosomes alleviate cerebral ischaemia-reperfusion injury through suppressing inflammatory response. Cell Prolif. 2021; 54(8):e13093. PMC: 8349657. DOI: 10.1111/cpr.13093. View

2.
Barzegar M, Wang Y, Eshaq R, Yun J, Boyer C, Cananzi S . Human placental mesenchymal stem cells improve stroke outcomes via extracellular vesicles-mediated preservation of cerebral blood flow. EBioMedicine. 2020; 63:103161. PMC: 7753936. DOI: 10.1016/j.ebiom.2020.103161. View

3.
Rao D, Sang C, Lai Z, Zhong J, Tang Z . Roles of Extracellular Vesicles in Cerebral Protection of Ischemic Stroke. Neuro Endocrinol Lett. 2021; 42(3):160-170. View

4.
Liu Y, Li Y, Xiao L, Chen L, Zheng S, Zeng E . Extracellular vesicles derived from M2 microglia reduce ischemic brain injury through microRNA-135a-5p/TXNIP/NLRP3 axis. Lab Invest. 2021; 101(7):837-850. DOI: 10.1038/s41374-021-00545-1. View

5.
Han M, Cao Y, Xue H, Chu X, Li T, Xin D . Neuroprotective Effect of Mesenchymal Stromal Cell-Derived Extracellular Vesicles Against Cerebral Ischemia-Reperfusion-Induced Neural Functional Injury: A Pivotal Role for AMPK and JAK2/STAT3/NF-κB Signaling Pathway Modulation. Drug Des Devel Ther. 2020; 14:2865-2876. PMC: 7381771. DOI: 10.2147/DDDT.S248892. View